乳腺筛查间期癌放射学回顾分类的系统综述:开放披露的方法学差异
该系统综述检索2000年1月至2019年5月间发表的文献,纳入46篇对基于人群乳腺筛查项目中间期乳腺癌进行回顾性放射学复阅与分类的研究。未发现任何研究以开放披露为目的进行回顾性复阅,复阅主要用于审计/质量保证及放射科医生教育等研究目的,复阅方法(复阅类型、复阅者数量、分类类别)存在差异,各研究中归为假阴性癌的比例为4%至40%。
要点
- 影像复阅将间期癌分为:筛查间期新发癌、既往筛查片上无明显恶性异常、筛查时未被检出三类。
- 各研究间期癌复阅后归为假阴性癌的比例范围为4%至40%,复阅方法差异可能影响分类结果。
- 未发现以开放披露为目的的回顾性复阅研究,现有复阅多用于审计/质量保证和放射科医生教育。
关键影像表现/征象
- 间期乳腺癌发生于乳腺筛查X线摄影阴性之后、筛查项目下次预约之前。
- 放射学复阅将间期癌分类为筛查间期发生的癌、既往筛查片上无明显恶性异常的癌、筛查时未检出的癌。
诊断标准与关键数值
- 各研究中假阴性癌占复阅间期癌的比例范围为4%至40%。
临床应用与阅片要点
- 间期癌复阅分类可用于筛查项目审计/质量保证及放射科医生教育和学习。
- 复阅方法(非盲法/半知情法)、复阅者数量和分类类别的差异可能影响分类结果的一致性。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
INTRODUCTION: Interval breast cancers occur following a negative breast screening mammogram and before the next scheduled appointment within screening programmes. Radiological review classifies them as cancers that develop between screens, cancers with no obvious malignant abnormalities on prior screens or cancers not detected at screening. This study aimed to systematically review published literature on the occurrence of open disclosure following interval cancer radiological reviews by breast screening programmes internationally in a retrospective setting and examine methodologies used for radiological reviews for the purposes of disclosure.
METHODS: A search for relevant articles published (January 2000 - May 2019) was conducted according to PICO and PRISMA guidelines. The databases Pubmed, Scopus, Google Scholar, Cinahl, Web of Science, Embase, Science Direct and Global Health were searched. Relevant studies were reviewed if they had completed a retrospective review and classification of interval breast cancers.
RESULTS: Of 46 relevant articles included, no study was identified that conducted a retrospective review purposely for open disclosure. Retrospective reviews were conducted for audit/quality assurance, and research including for radiologist education and learning. Variation in methodology was found across review type (non-blinded/semi-informed approach), number of reviewers and classification categories. The proportion of false negative cancers classified among the studies ranged from 4 to 40 %.
DISCUSSION: Variation among radiological review practices were observed, which likely impacts classification results. To ensure standardised classification of interval breast cancers are employed for the purposes of open disclosure in screening settings, reproducible and consistent methodology is required.
引用
- Mullooly M, White G, Bennett K, et al. Retrospective radiological review and classification of interval breast cancers within population-based breast screening programmes for the purposes of open disclosure: A systematic review. Eur J Radiol. 2021. PMID: 33726976. doi:10.1016/j.ejrad.2021.109572
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。